Cargando…

The burden of medication overuse headache and patterns of switching and discontinuation among triptan users: a systematic literature review

BACKGROUND: A synthesis of real-world discontinuation and switching patterns among triptan users and rates of acute medication use among patients with medication overuse headache (MOH) is needed to better understand the burden among patients with migraine. The study objectives were to: (1) synthesiz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deighton, Alison M., Harris, Linda A., Johnston, Karissa, Hogan, Shomari, Quaranta, Lynn A., L’Italien, Gilbert, Coric, Vlad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561931/ https://www.ncbi.nlm.nih.gov/pubmed/34727873 http://dx.doi.org/10.1186/s12883-021-02451-x

Ejemplares similares

Monthly migraine days, tablet utilization, and quality of life associated with Rimegepant – post hoc results from an open label safety study (BHV3000–201)
por: Johnston, Karissa, et al.
Publicado: (2022)

Rimegepant, Ubrogepant, and Lasmiditan in the Acute Treatment of Migraine Examining the Benefit-Risk Profile Using Number Needed to Treat/Harm
por: Johnston, Karissa M, et al.
Publicado: (2022)

Increased activity of serotonin uptake in platelets in medication overuse headache following regular intake of analgesics and triptans
por: Ayzenberg, Ilya, et al.
Publicado: (2008)

Increased activity of serotonin uptake in platelets in medication overuse headache following regular intake of analgesics and triptans
por: Ayzenberg, Ilya, et al.
Publicado: (2008)

Measuring interictal burden among people affected by migraine: a descriptive survey study
por: Hubig, Lena T., et al.
Publicado: (2022)

Matching‐adjusted indirect comparisons of oral rimegepant versus placebo, erenumab, and galcanezumab examining monthly migraine days and health‐related quality of life in the treatment of migraine
por: Popoff, Evan, et al.
Publicado: (2021)

Maladaptive activation of Nav1.9 channels by nitric oxide causes triptan-induced medication overuse headache
por: Bonnet, Caroline, et al.
Publicado: (2019)

Real-World experience of interictal burden and treatment in migraine: a qualitative interview study
por: Lo, Siu Hing, et al.
Publicado: (2022)

Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine
por: Gentile, Giovanna, et al.
Publicado: (2010)

Mapping Migraine-Specific Quality of Life to Health State Utilities in Patients Receiving Rimegepant
por: Johnston, Karissa M., et al.
Publicado: (2021)

Health State Utility Mapping of Rimegepant for the Preventive Treatment of Migraine: Double-Blind Treatment Phase and Open Label Extension (BHV3000-305)
por: Powell, Lauren C., et al.
Publicado: (2022)

Author Correction: Maladaptive activation of Nav1.9 channels by nitric oxide causes triptan-induced medication overuse headache
por: Bonnet, Caroline, et al.
Publicado: (2021)

Use of triptans for the control of headache in bacterial meningitis
por: Wiwanitkit, Viroj
Publicado: (2014)

A stated preference survey to explore patient preferences for novel preventive migraine treatments
por: Hubig, Lena T., et al.
Publicado: (2022)

Headaches related to triptans therapy in patients of migrainous vertigo
por: Prakash, Sanjay, et al.
Publicado: (2008)

Use and overuse of triptans in Austria – a survey based on nationwide healthcare claims data
por: Zebenholzer, Karin, et al.
Publicado: (2018)

Careful consideration for use of triptans for the control of headache in bacterial meningitis
por: Mojumder, Deb Kumar
Publicado: (2014)

Hair analysis for detection of triptans occasionally used or overused by migraine patients—a pilot study
por: Ferrari, Anna, et al.
Publicado: (2016)

Consistency vs. switching triptan treatment and headache-related disability: Results of the American migraine prevalence & prevention study
por: Buse, DC, et al.
Publicado: (2013)

Costs and Utilization of Triptan Users Who Receive Drug Prophylaxis for Migraine Versus Triptan Users Who Do Not Receive Drug Prophylaxis
por: Etemad, Lida R., et al.
Publicado: (2005)

Triptans Use for Migraine Headache among Nonelderly Adults with Cardiovascular Risk
por: Alwhaibi, Monira, et al.
Publicado: (2016)

Medication-overuse headache: an update
por: Sarchielli, Paola
Publicado: (2015)

Triptan non-response in specialized headache care: cross-sectional data from the DMKG Headache Registry
por: Ruscheweyh, Ruth, et al.
Publicado: (2023)

Real‐world assessment of the relationship between migraine‐related disability and healthcare costs in the United States
por: Harris, Linda, et al.
Publicado: (2022)

Observational Analysis of the Costs Associated with Acute Treatment of Breakthrough Migraine Attacks in Medicaid Patients Using Preventive Therapies
por: Harris, Linda, et al.
Publicado: (2023)

Medication–overuse headache: pathophysiological insights
por: Calabresi, P., et al.
Publicado: (2005)

Medication-overuse headache: a review
por: Kristoffersen, Espen Saxhaug, et al.
Publicado: (2014)

Preventing and treating medication overuse headache
por: Alstadhaug, Karl B., et al.
Publicado: (2017)

Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline
por: Diener, Hans-Christoph, et al.
Publicado: (2022)

Theoretical analysis of headache recurrence in patients administered triptans for migraine based on receptor occupancy
por: Tokuoka, Kentaro, et al.
Publicado: (2015)

Medication Overuse and Headache Burden: Results From the CaMEO Study
por: Schwedt, Todd J., et al.
Publicado: (2021)

Treatment and outcome in medication overuse headache patients
por: Mitsikostas, D, et al.
Publicado: (2013)

EHMTI-0303. Treatment of medication overuse headache
por: Madsen, SK, et al.
Publicado: (2014)

Cortical and Subcortical Alterations in Medication Overuse Headache
por: Mehnert, Jan, et al.
Publicado: (2018)

Severity of Analgesic Dependence and Medication-overuse Headache
por: Lundqvist, Christofer, et al.
Publicado: (2019)

Medication-overuse headache: causes, consequences and management
por: Massey, Thomas H., et al.
Publicado: (2021)

Team players against headache: multidisciplinary treatment of primary headaches and medication overuse headache
por: Gaul, Charly, et al.
Publicado: (2011)

Nasal decongestant and chronic headache: a case of naphazoline overuse headache?
por: Di Lorenzo, Cherubino, et al.
Publicado: (2013)

All triptans are not the same
por: Rapoport, Alan M., et al.
Publicado: (2001)

Clinical experience with triptans
por: Zanchin, Giorgio, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_ioo20ff6hokqirch1j6sj5b1ug